Antimicrobial Susceptibility Pattern of Clinical Isolates of Pseudomonas Aeruginosa in a Pediatric Hospital
محل انتشار: فصلنامه آسیب شناسی ایران، دوره: 2، شماره: 4
سال انتشار: 1386
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 751
فایل این مقاله در 5 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJP-2-4_001
تاریخ نمایه سازی: 5 آبان 1393
چکیده مقاله:
Background and Objective: Pseudomonas aeruginosa has become a frequent cause of nosocomial infections, particularly in intensive care units (ICUs). Many reports have documented high ratesof resistance in this species to commonly-used broad-spectrum antibiotics. The aim of this studywas to assess the in vitro activity of some antibiotics against Pseudomonas aeruginosa strains to determine the susceptibility patterns of isolates to different antibiotics.Materials and Methods: A total of 233 Pseudomonas aeruginosa isolates obtained from various clinical specimens of hospitalized children in Ali-Asghar hospital of Tehran (Iran) were considered for susceptibility test. These strains were tested against 12 different antibiotics by a disk diffusionmethod. Of these isolates, 33.9% were from trachea, 31.8% from urine, 6.9% from eye, 5.2% from blood, 5.1% from ear, 1.3% from cerebrospinal fluid, 1.2% from stool, and 14.6% from other sites. In addition, 48.5% of P. aeruginosa strains were isolated from patients in ICUs.Results: The most active antimicrobials were amikacin and other active compounds were gentamicin, ceftazidime, and ciprofloxacin respectively. Isolates from ICUs were more resistantto amikacin and gentamicin as compared to those from non-ICU wards (p<0.05). Isolates fromtrachea were more resistant to amikacin, gentamicin, ciprofloxacin and ceftazidime than those from other sites (p<0.05).Conclusion: Our study showed that amikacin was the most active agent against P. aeruginosafollowed by gentamycin, ceftazidime, and ciprofloxacin. According to our in vitro study results, active antibiotic susceptibility testing and surveillance should be continued in order to curtail the problem of antibiotic resistance.
کلیدواژه ها:
نویسندگان
Sara Jam
Iranian Research Center for HIV/AIDS, Tehran, Iran
Duman Sabzevari
Iranian Research Center for HIV/AIDS, Tehran, Iran
Arezoo Aghakhani
Clinical Research Dept., Pasteur Institute of Iran, Tehran, Iran
Ali Eslamifar
Clinical Research Dept., Pasteur Institute of Iran, Tehran, Iran